SWS Academic Research eLibraryEarth & Planetary Sciences

Scholarly record

PREPARATION AND THERMAL STABILITY EVALUATION OF SOLID LIPID PARTICLES LOADED WITH ALENDRONATE

Ochiuz, Lacramioara, Tomoiaga, Alina, Grigoras, Anca, Grigoras, Cristian, Profire, Lenuta, Peptu, Catalina, Popa, Gratiela

First published: 2014-06-20https://doi.org/10.5593/sgem2014/b61/s24.021View metrics

Publication Impact Profile

PlumX
  • Citations
  • CrossRef - Citation Indexes: 1
  • Captures
  • Mendeley - Readers: 10
PLUMX see details

Publication details

Title
PREPARATION AND THERMAL STABILITY EVALUATION OF SOLID LIPID PARTICLES LOADED WITH ALENDRONATE
Authors
Ochiuz, Lacramioara, Tomoiaga, Alina, Grigoras, Anca, Grigoras, Cristian, Profire, Lenuta, Peptu, Catalina, Popa, Gratiela
Proceedings
SGEM International Multidisciplinary Scientific GeoConference EXPO Proceedings; 14th SGEM GeoConference on NANO, BIO AND GREEN TECHNOLOGIES FOR A SUSTAINABLE FUTURE
Publisher
Stef92 Technology
Year
2014
Pages
Not available yet
ISSN
1314-2704
ISBN
978-619-7105-20-9
Language
en
Publication type
Conference Paper
Keywords
Environmental LegislationMultilateral Relations and Funding Opportunities
References30

  1. Roelofs A. J. , Ebetino H. F. & Reszka A. A. Bisphosphonates: Mecanism of Actions, in Bilezikian P. J., Raiz Martin T. J. (eds), Principles of Bone Biology. 3rd edition, New York: Academic Press Inc., USA, pp. 333 -368, 2008.

  2. Binkley N., Ringe J.D. & Reed J.I. Alendronate/vitamin D3 70/2800 with and without additional 2800 IU vitamin D3 for osteoporosis: results from the 24-week extension of a 15-week randomized, controlled trial, Bone, vol. 44, pp. 639 – 647, 2009.

  3. Fleish H. Bisphosphonates in bone diseases: from the laboratory to the patient, Academic Press, USA, pp 2-3, 2003.

  4. Bartl R. & Frisch B. Bisphosphonates in medical practice, Springer, USA, 7-27, 2005. 14th SGEM GeoConference on Nano, Bio and Green – Technologies for a Sustainable Future

  5. Cremers S. & Papapoulos S. Pharmacology of bisphosphonates, Bone, vol. 49, pp. 42 - 49, 2011.

  6. Kusamori K., Katsumi H., Abe M. , Ueda A., Sakai R., Hayashi R., Hirai Y., Quan Y. S., Kamiyama F., Sakane T., Yamamoto A. Development of a novel transdermal patch of alendronate, a nitrogen-containing bisphosphonate, for the treatment of osteoporosis, J Bone Miner Res. vol. 25 / issue 12, pp. 2582-2591, 2010.

  7. Cruz L., Assumpção E. , Andrade S. F., Conrado D. J. , Guterres S. S. , Pohlmann A. R. Microencapsulation of sodium alendronate reduces drug mucosal damages in rats, Drug Delivery, vol. 17 / issue 4, pp. 231-237, 2010.

  8. Asikoğlu M., Ozguney I., Ozcan I., Orumlu O., Guneri T., Koseoğlu K., Ozkilic H. The absorption of (99m)Tc-alendronate given by rectal route in rabbits, Pharm Dev Technol., vol. 13 / issue3, pp. 213 – 220, 2008.

  9. Katsumi H., Nakatani M., Sano J. I., Abe M., Kusamori K., Kurihara M, Shiota R., Takashima M., Fujita T., Sakane T., Hibi T., Yamamoto A. Absorption and safety af alendronate, a nitrogen -containing bisphosphonate, after intrapulmonary administration in rats, Int. J. Pharm., vol. 400, pp. 124-130, 2010.

  10. Bock O. & Felsenberg D. Bis phosphonates in the management of postmenopausal osteoporosis – optimizing efficacy in clinical practice, Clin. Interv. Aging, vol. 3 / issue 2, pp. 279 – 297, 2010.

  11. Parveen S., Misra R., Sahoo S. K., Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomedicine: NBM, vol. 8, pp. 147 – 166, 2012.

  12. Naahidi S., Jafari M., Edalat F., Raymond K., Khademhosseini A. Chen P. Biocompatibility of engineered nanoparticles for drug delivery, J. Control. Release, vol. 166, pp. 182 – 194, 2013.

  13. Merisko-Liversidge E. & Liversidge G. G. Drug nanoparticles: formulating poorly water-soluble compounds. Toxicol Pathol, vol 36 / issue 1, pp. 43 – 48, 2008.

  14. Briejesh T. & Singh N. Pulse Chemistry and Technology, The Royal Society and Chemistry Publisher, UK, pp. 134 – 138, 2012.

  15. Thoke S.B., Sharma Y.P., Rawat S.S., Nangude S.L., Formulation development & evaluation of effervescent tablet of Alendronate sodium with vitamin D3, Journal of Drug Delivery and Therapeutics, vol. 3 / issue 5, pp. 65 – 74, 2013.

  16. Roelofs A. J. , Ebetino H. F. & Reszka A. A. Bisphosphonates: Mecanism of Actions, in Bilezikian P. J., Raiz Martin T. J. (eds), Principles of Bone Biology. 3rd edition, New York: Academic Press Inc., USA, pp. 333 -368, 2008.

  17. Binkley N., Ringe J.D. & Reed J.I. Alendronate/vitamin D3 70/2800 with and without additional 2800 IU vitamin D3 for osteoporosis: results from the 24-week extension of a 15-week randomized, controlled trial, Bone, vol. 44, pp. 639 – 647, 2009.

  18. Fleish H. Bisphosphonates in bone diseases: from the laboratory to the patient, Academic Press, USA, pp 2-3, 2003.

  19. Bartl R. & Frisch B. Bisphosphonates in medical practice, Springer, USA, 7-27, 2005. 14th SGEM GeoConference on Nano, Bio and Green – Technologies for a Sustainable Future

  20. Cremers S. & Papapoulos S. Pharmacology of bisphosphonates, Bone, vol. 49, pp. 42 - 49, 2011.

  21. Kusamori K., Katsumi H., Abe M. , Ueda A., Sakai R., Hayashi R., Hirai Y., Quan Y. S., Kamiyama F., Sakane T., Yamamoto A. Development of a novel transdermal patch of alendronate, a nitrogen-containing bisphosphonate, for the treatment of osteoporosis, J Bone Miner Res. vol. 25 / issue 12, pp. 2582-2591, 2010.

  22. Cruz L., Assumpção E. , Andrade S. F., Conrado D. J. , Guterres S. S. , Pohlmann A. R. Microencapsulation of sodium alendronate reduces drug mucosal damages in rats, Drug Delivery, vol. 17 / issue 4, pp. 231-237, 2010.

  23. Asikoğlu M., Ozguney I., Ozcan I., Orumlu O., Guneri T., Koseoğlu K., Ozkilic H. The absorption of (99m)Tc-alendronate given by rectal route in rabbits, Pharm Dev Technol., vol. 13 / issue3, pp. 213 – 220, 2008.

  24. Katsumi H., Nakatani M., Sano J. I., Abe M., Kusamori K., Kurihara M, Shiota R., Takashima M., Fujita T., Sakane T., Hibi T., Yamamoto A. Absorption and safety af alendronate, a nitrogen -containing bisphosphonate, after intrapulmonary administration in rats, Int. J. Pharm., vol. 400, pp. 124-130, 2010.

  25. Bock O. & Felsenberg D. Bis phosphonates in the management of postmenopausal osteoporosis – optimizing efficacy in clinical practice, Clin. Interv. Aging, vol. 3 / issue 2, pp. 279 – 297, 2010.

  26. Parveen S., Misra R., Sahoo S. K., Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomedicine: NBM, vol. 8, pp. 147 – 166, 2012.

  27. Naahidi S., Jafari M., Edalat F., Raymond K., Khademhosseini A. Chen P. Biocompatibility of engineered nanoparticles for drug delivery, J. Control. Release, vol. 166, pp. 182 – 194, 2013.

  28. Merisko-Liversidge E. & Liversidge G. G. Drug nanoparticles: formulating poorly water-soluble compounds. Toxicol Pathol, vol 36 / issue 1, pp. 43 – 48, 2008.

  29. Briejesh T. & Singh N. Pulse Chemistry and Technology, The Royal Society and Chemistry Publisher, UK, pp. 134 – 138, 2012.

  30. Thoke S.B., Sharma Y.P., Rawat S.S., Nangude S.L., Formulation development & evaluation of effervescent tablet of Alendronate sodium with vitamin D3, Journal of Drug Delivery and Therapeutics, vol. 3 / issue 5, pp. 65 – 74, 2013.

Citing literature

Number of times cited according to Crossref: 1

Open DOICrossref metadataOpenCitations
View or Download full articleAccess options
Full paper accessChoose SWS login, librarian support, or instant article download.

SWS access login

Login as SWS Scientific Committee

Authors and approved SWS contributors will read and export their own linked papers after identity matching by SWS profile, email and SGEM GlobalID.

For librarian assistance: [email protected]

Purchase Instant Access

48-hour online accessComing soon
Online-only accessComing soon
Download the full article in PDF formatEUR 35
  • Article can be downloaded after successful payment.
  • Article may be used according to SWS library access terms.
  • Article cannot be redistributed.
Get full paper

Back to publication list